AWM Investment Company Inc. Acquires Shares of 237,169 OrthoPediatrics Corp. $KIDS

Key Points

• AWM Investment Company acquired 237,169 OrthoPediatrics shares worth approximately $4.54 million, representing about 0.91% of the company. Institutional investors collectively own 69.05% of KIDS.
• OrthoPediatrics exceeded quarterly expectations, reporting an adjusted loss of $0.26 per share versus the $0.30 consensus estimate and revenue of $70.51 million versus $68.21 million expected. The company remains unprofitable, with a 15.72% negative net margin.
• Analyst sentiment is broadly positive: nine analysts rate the stock Buy, while the consensus is Moderate Buy with an average price target of $26.44, compared with a recent share price of $24.50.

AWM Investment Company Inc. purchased a new stake in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 237,169 shares of the company's stock, valued at approximately $4,537,000. AWM Investment Company Inc. owned approximately 0.91% of OrthoPediatrics at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of KIDS. BlackRock Inc. purchased a new position in OrthoPediatrics during the second quarter worth approximately $24,347,000. Millennium Management LLC grew its stake in shares of OrthoPediatrics by 48.0% during the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company's stock valued at $24,802,000 after buying an additional 452,840 shares during the period. AIGH Capital Management LLC acquired a new stake in shares of OrthoPediatrics during the 2nd quarter worth $5,161,000. Granahan Investment Management LLC increased its holdings in shares of OrthoPediatrics by 35.1% during the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company's stock worth $14,231,000 after buying an additional 232,760 shares during the last quarter. Finally, Wasatch Advisors LP raised its position in shares of OrthoPediatrics by 56.6% in the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company's stock worth $9,865,000 after buying an additional 186,357 shares during the period. Institutional investors and hedge funds own 69.05% of the company's stock.

OrthoPediatrics Trading Down 2.3%

NASDAQ KIDS opened at $24.50 on Wednesday. The stock has a market cap of $639.70 million, a P/E ratio of -14.58 and a beta of 0.98. The company's fifty day simple moving average is $21.11 and its 200-day simple moving average is $18.53. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a 52 week low of $14.42 and a 52 week high of $26.74.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, topping analysts' consensus estimates of ($0.30) by $0.04. The firm had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. Equities research analysts predict that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

KIDS has been the subject of several research analyst reports. BTIG Research upped their price target on OrthoPediatrics from $24.00 to $29.00 and gave the stock a "buy" rating in a research note on Thursday, August 20th. Needham & Company LLC boosted their target price on OrthoPediatrics from $30.00 to $35.00 and gave the stock a "buy" rating in a report on Wednesday, August 5th. TD Cowen reiterated a "buy" rating on shares of OrthoPediatrics in a report on Monday, June 15th. Piper Sandler reissued an "overweight" rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Finally, Truist Financial set a $22.00 price target on shares of OrthoPediatrics in a report on Wednesday, August 5th. Nine investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, OrthoPediatrics currently has a consensus rating of "Moderate Buy" and an average price target of $26.44.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company's product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.

Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source